The Market For DNA-Sequncing-Based Down’s Syndrome Tests Could Exceed $6 Billion


On Wednesday night the New England Journal of Medicine published a study showing that a new, DNA-sequencing based blood test provides a dramatic improvement in accuracy at screening for Down’s...

The $1,000 Genome Arrives — For Real, This Time


Today, Illumina, the leading maker of DNA sequencers, announced a milestone in biotechnology: it is introducing a new machine that can sequence the genetic code of a human cell for $1,000. The...